Immunotherapy for recurrent malignant glioma: an interim report on survival.
暂无分享,去创建一个
J. Buckwalter | M. Ingram | G. Techy | R. Rand | D. Jacques | C. Shelden | K. Miyagi | D. B. Freshwater | R. M. Abts | L. W. English
[1] R. Merchant,et al. Adoptive immunotherapy for recurrent glioblastoma multiforme using lymphokine activated killer cells and recombinant interleukin‐2 , 1988, Cancer.
[2] P. Gutin,et al. Recurrent malignant gliomas: survival following interstitial brachytherapy with high-activity iodine-125 sources. , 1987, Journal of neurosurgery.
[3] S. Jacques,et al. Salvage immunotherapy of malignant glioma. , 1987, Archives of surgery.
[4] M. Ammirati,et al. Reoperation in the treatment of recurrent intracranial malignant gliomas. , 1987, Neurosurgery.
[5] P. Gutin,et al. Reoperation for recurrent glioblastoma and anaplastic astrocytoma. , 1987, Neurosurgery.
[6] S. Jacques,et al. Preliminary clinical trial of immunotherapy for malignant glioma. , 1987, Journal of biological response modifiers.
[7] A. Ciampi,et al. Malignant gliomas of the brain. A retrospective study. , 1986, Surgical neurology.
[8] P. Burger,et al. Malignant astrocytic neoplasms: classification, pathologic anatomy, and response to treatment. , 1986, Seminars in oncology.
[9] Jung Sun Kim,et al. Response of astrocytoma to high‐dose methotrexate with citrovorum factor rescue , 1985, Cancer.
[10] S. Rosenberg,et al. Lymphokine-activated killer cell phenomenon. II. Precursor phenotype is serologically distinct from peripheral T lymphocytes, memory cytotoxic thymus-derived lymphocytes, and natural killer cells , 1983, The Journal of experimental medicine.
[11] M. Salcman,et al. Effect of age and reoperation on survival in the combined modality treatment of malignant astrocytoma. , 1982, Neurosurgery.
[12] W. Markesbery,et al. Reoperation for glioblastoma. , 1981, Journal of neurosurgery.